Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Food and Drug Administration
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Office of Criminal Investigations ==== [[File:US Food and Drug Administration Office 20180930.jpg|thumb|Jamaica, Queens, New York Regional Office - USFDA]] The [[Office of Criminal Investigations]] was established in 1991 to investigate criminal cases. To do so, OCI employs approximately 200 Special Agents nationwide who, unlike ORA Investigators, are armed, have badges, and do not focus on technical aspects of the regulated industries. Rather, OCI agents pursue and develop cases when individuals and companies commit criminal actions, such as fraudulent claims or knowingly and willfully shipping known adulterated goods in interstate commerce. In many cases, OCI pursues cases involving violations of [[Title 18 of the United States Code]] (e.g., conspiracy, false statements, wire fraud, mail fraud), in addition to prohibited acts as defined in Chapter III of the FD&C Act. OCI Special Agents often come from other criminal investigations backgrounds, and frequently work closely with the [[Federal Bureau of Investigation]], [[United States Assistant Attorney General|Assistant Attorney General]], and even [[Interpol]]. OCI receives cases from a variety of sources—including ORA, local agencies, and the [[Federal Bureau of Investigation|FBI]], and works with ORA Investigators to help develop the technical and science-based aspects of a case.<ref>{{Cite journal | author = Office of Regulatory Affairs |date=October 7, 2021 |title=About OCI |url=https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/criminal-investigations/about-oci |journal=FDA |language=en |access-date=January 14, 2023 |archive-date=January 14, 2023 |archive-url=https://web.archive.org/web/20230114025654/https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/criminal-investigations/about-oci |url-status=dead }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)